Its upregulation concomitantly induced activation of AKT through the TGFβ pathway and regulation of EGFR activity and was highly correlated with epithelial-mesenchymal transition (EMT) and resistance to erlotinib in osteosarcoma cancer stem cell–like cells (Wang et al., 2019). The gene discussed is AKT1; the disease is cancer.